Fastin-XR By Hi-Tech Pharmaceuticals Overview & Drug Interactions

Check For Interactions With Fastin-XR

Supplement: Fastin-XR by Hi-Tech Pharmaceuticals

Fastin-XR Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Fastin-XR by Hi-Tech Pharmaceuticals

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
Servings per container 90
UPC/BARCODE 857084000675

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Fastin Extended Release Proprietary Blend
375 mg
Proprietary Blend (Combination) --
Acacia rigidula extract
0 NP
Blackbrush
Phenylethylamine Alkoloids
200 mg
Phenethylamine
Synephrine
0 NP
Synephrine
Theobromine
0 NP
Theobromine
Green Tea
0 NP
Green Tea
1,3-Dimethylamylamine
0 NP
1,3-DMAA
Naringen
0 NP
Naringenin
5-Methoxytryptamine HCl
0 NP
5-Methoxytryptamine
Yohimbine HCl
0 NP
Yohimbine
Caffeine Anhydrous
150 mg
Caffeine --

Other Ingredients:
Hydroxypropyl Methylcellulose
Dicalcium Phosphate
Sodium Starch Glycolate
Magnesium Stearate
Silica
FD&C Blue #1
FD&C Red #40
FD&C Yellow #6


Label Statments:


FDA Disclaimer Statement
- THESE STATEMENTS HAVE NOT BEEN APPROVED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.
Precautions
- INDIVIDUALS WHO CONSUME CAFFEINE WITH THIS PRODUCT MAY EXPERIENCE SERIOUS ADVERSE HEALTH EFFECTS. INDIVIDUALS WHO ARE SENSITIVE TO THE EFFECTS OF CAFFEINE SHOULD CONSULT A LICENSED HEALTH CARE PROFESSIONAL BEFORE CONSUMING THIS PRODUCT. (WARNING.INFORMATION CONTINUED ON BACK OF LABEL.)
- IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY. AVOID ALCOHOL WHILE TAKING THIS PRODUCT. DO NOT EXCEED RECOMMENDED SERVING. EXCEEDING RECOMMENDED SERVING MAY CAUSE SERIOUS ADVERSE HEALTH EFFECTS, INCLUDING HEART ATTACK AND STROKE. DISCONTINUE USE AND CALL A PHYSICIAN OR LICENSED QUALIFIED HEALTH CARE PROFESSIONAL IMMEDIATELY IF YOU EXPERIENCE RAPID HEARTBEAT, DIZZINESS, SEVERE HEADACHE, SHORTNESS OF BREATH, OR OTHER SIMILAR SYMPTOMS. IMPROPER USE OF THIS PRODUCT MAY BE HAZARDOUS TO A PERSON'S HEALTH. EXCEEDING RECOMMENDED SERVING WILL NOT IMPROVE RESULTS.
- WARNING: NOT FOR USE BY INDIVIDUALS UNDER THE AGE OF 18 YEARS.
- DO NOT USE IF YOU ARE PREGNANT OR NURSING.
- SALE TO PERSONS 17 YEARS OF AGE OR YOUNGER IS PROHIBITED
- Tamper Evident Do Not Use If Printed Seal Is Cut, Torn or Missing
Seals/Symbols
- HTP HI-TECH PHARMACEUTICALS
FDA Statement of Identity
- DIETARY SUPPLEMENT
General Statements
- EXTENDED RELEASE CAPSULES
- THE WORLD'S MOST ADVANCED WEIGHT LOSS AID EVER DEVELOPED WITH EXTENDED RELEASE TECHNOLOGY!
- REVOLUTIONARY FAT LOSS CATALYST & APOPTOSIS AGENT
- PEEL HERE
- 525 mg
- To report adverse effects call FDA's MedWatch at 1.800.332.1088
Suggested/Recommended/Usage/Directions
- Dosage: Take 1-2 capsules in the morning and 1 capsule after lunch. Do not exceed 4 capsules daily.

Brand Information

See all products by this brand

Manufacturer
Name Hi-Tech Pharmaceuticals, Inc.
Street Address 6015-B Unity Dr.
City Norcross
State GA
ZipCode 30071
Phone Number 1-888-855-7919
Web Address www.hitechpharma.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.